Cargando…

Lorcaserin for weight management

Type 2 diabetes and obesity commonly occur together. Obesity contributes to insulin resistance, a main cause of type 2 diabetes. Modest weight loss reduces glucose, lipids, blood pressure, need for medications, and cardiovascular risk. A number of approaches can be used to achieve weight loss, inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taylor, James R, Dietrich, Eric, Powell, Jason
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684144/ https://www.ncbi.nlm.nih.gov/pubmed/23788837 http://dx.doi.org/10.2147/DMSO.S36276

Ejemplares similares

The use of lorcaserin in the management of obesity: a critical appraisal
por: Bai, Bo, et al.
Publicado: (2010)

Formulary Management of 2 New Agents: Lorcaserin and Phentermine/Topiramate for Weight Loss
por: Kelly, Elizabeth M., et al.
Publicado: (2013)

Lorcaserin and metabolic disease: weight‐loss dependent and independent effects
por: Bays, H., et al.
Publicado: (2018)

Coadministration of lorcaserin and phentermine for weight management: A 12‐week, randomized, pilot safety study
por: Smith, Steven R., et al.
Publicado: (2017)

Lorcaserin: A novel antiobesity drug
por: Brashier, Dick B. S., et al.
Publicado: (2014)

RF24 | PSUN95 Defining Predictors of Weight Loss Response to Lorcaserin
por: Gugger, Aristea Sideri, et al.
Publicado: (2022)

Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release
por: Hurt, Ryan T, et al.
Publicado: (2018)

Varenicline and Lorcaserin for Smoking Cessation and Weight Gain Prevention: A Randomized Clinical Trial
por: Hurt, Ryan T., et al.
Publicado: (2022)

A randomized, open-label pilot of the combination of low-level laser therapy and lorcaserin for weight loss
por: Croghan, Ivana T., et al.
Publicado: (2016)

Lorcaserin for the treatment of obesity? A closer look at its side effects
por: DiNicolantonio, James J, et al.
Publicado: (2014)

Lorcaserin improves glycemic control via a melanocortin neurocircuit
por: Burke, Luke K., et al.
Publicado: (2017)

Lorcaserin therapy for severe epilepsy of childhood onset: A case series
por: Tolete, Patricia, et al.
Publicado: (2018)

Lorcaserin and phentermine exert anti-obesity effects with modulation of the gut microbiota
por: Song, Eun-Ji, et al.
Publicado: (2023)

Effects of lorcaserin on pre‐existing valvulopathy: A pooled analysis of phase 3 trials
por: Weissman, Neil J., et al.
Publicado: (2016)

Pimavanserin and Lorcaserin Attenuate Measures of Binge Eating in Male Sprague-Dawley Rats
por: Price, Amanda E., et al.
Publicado: (2018)

Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain
por: Di Giovanni, Giuseppe, et al.
Publicado: (2020)

Lorcaserin Inhibit Glucose-Stimulated Insulin Secretion and Calcium Influx in Murine Pancreatic Islets
por: Jing, Muhan, et al.
Publicado: (2021)

Hypothesis: Amelioration of obesity‐induced cognitive dysfunction via a lorcaserin–betahistine combination treatment
por: dela Peña, Ike C., et al.
Publicado: (2022)

Effect of lorcaserin on weight reduction in persons with obstructive sleep apnea (OSA): a combined subgroup analysis from three randomized, controlled clinical trials
por: Fujioka, K., et al.
Publicado: (2019)

Canagliflozin: a novel treatment option for type 2 diabetes
por: Dietrich, Eric, et al.
Publicado: (2013)

Safety and Preliminary Efficacy of Lorcaserin for Cocaine Use Disorder: A Phase I Randomized Clinical Trial
por: Johns, Sade E., et al.
Publicado: (2021)

Effect of Lorcaserin Alone and in Combination with Phentermine on Food Cravings after 12 week-treatment: Randomized Sub-study
por: Rebello, Candida, et al.
Publicado: (2018)

Chronic Lorcaserin Treatment Reverses the Nicotine Withdrawal-Induced Disruptions to Behavior and Maturation in Developing Neurons in the Hippocampus of Rats
por: Zaniewska, Magdalena, et al.
Publicado: (2021)

Lorcaserin vs. Phentermine among non-surgical and surgical obese patients: Anthropometric, glycemic, lipid, safety and cost outcomes
por: Elhag, Wahiba, et al.
Publicado: (2019)

Inhibition of Cocaine and 3,4-Methylenedioxypyrovalerone (MDPV) Self-Administration by Lorcaserin Is Mediated by 5-HT2C Receptors in Rats
por: Gannon, Brenda M., et al.
Publicado: (2018)

Lorcaserin for prevention and remission of type 2 diabetes mellitus in people with overweight or obesity: protocol for a systematic review and meta-analysis
por: Zeng, Hai, et al.
Publicado: (2019)

Effect of lorcaserin in different age groups: a post hoc analysis of patients from the BLOOM, BLOSSOM and BLOOM‐DM studies
por: Fujioka, K., et al.
Publicado: (2019)

Characterization of the 5-HT(2C) receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet-induced obesity
por: Higgins, Guy A, et al.
Publicado: (2015)

Pilot study of extended-release lorcaserin for cocaine use disorder among men who have sex with men: A double-blind, placebo-controlled randomized trial
por: Santos, Glenn-Milo, et al.
Publicado: (2021)

Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression
por: Wagner, Stefan, et al.
Publicado: (2022)

The 5-HT(2C) receptor agonist, lorcaserin, and the 5-HT(6) receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour
por: Higgs, Suzanne, et al.
Publicado: (2015)

Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia
por: Anderson, Morgan, et al.
Publicado: (2014)

Endocannabinoids in Body Weight Control
por: Horn, Henrike, et al.
Publicado: (2018)

Weight Management in Young Adults: Systematic Review of Electronic Health Intervention Components and Outcomes
por: Willmott, Taylor Jade, et al.
Publicado: (2019)

Off-label drugs for weight management
por: Hendricks, Ed J
Publicado: (2017)

Wegovy (semaglutide): a new weight loss drug for chronic weight management
por: Singh, Gurdeep, et al.
Publicado: (2022)

Pharmacological Treatments and Natural Biocompounds in Weight Management
por: Gasmi, Amin, et al.
Publicado: (2023)

‘Small Changes’ to Diet and Physical Activity Behaviors for Weight Management
por: Hills, Andrew P., et al.
Publicado: (2013)

Weight management in obesity – past and present
por: Haslam, D.
Publicado: (2016)

Management of Weight Loss in People With Cancer
por: Hager, Kristy K.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p4tcfnrktgr385u9s4pnmq8v23